Health, Fitness & Food

Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG
0 Comments
In this article ME Follow your favorite stocksCREATE FREE ACCOUNT Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023.  Jordan Vonderhaar | Bloomberg | Getty Images Embattled genetic testing company 23andMe said on Tuesday that it’s started exploring
0 Comments
In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT U.S. President Donald Trump attends a House Republican members conference meeting in Trump National Doral resort, in Miami, Florida, U.S. Jan. 27, 2025.  Elizabeth Frantz | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news
0 Comments
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of GEHC, decreasing its weighting to about 2.25% from 2.42%. We’re taking advantage of the market’s rotation into health-care stocks by locking in profits in GE Healthcare. Following an up-and-down 2024, GE
0 Comments
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on
0 Comments
In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealthcare on Thursday tapped company veteran Tim Noel as its new CEO following the targeted killing of its former top executive, Brian
0 Comments
In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT This photo provided by Janssen Global Services shows Spravato nasal spray. Janssen Global Services via AP The Food and Drug Administration on Tuesday approved Johnson & Johnson‘s nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat,
0 Comments
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New York City after spending nearly a
0 Comments
In this article Follow your favorite stocksCREATE FREE ACCOUNT The Waystar team celebrates its IPO at the Nasdaq 2024 Nasdaq, Inc. / Vanja Savic Health-care payments company Waystar on Monday announced a new generative artificial intelligence tool that can help hospitals quickly tackle one of their most costly and tedious responsibilities: fighting insurance denials.  Hospitals
0 Comments
In this article GSK ABBV BMY PFE NVO NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  George Frey | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations
0 Comments
U.S. Sen. Bernie Sanders (I-VT) speaks about prescription drug costs during an event at NHTI Concord Community College in Concord, New Hampshire, U.S., October 22, 2024.  Elizabeth Frantz | Reuters Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see massive savings, despite changes in premiums, according to
0 Comments
In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb believes Alzheimer’s is the largest market for its newly approved schizophrenia drug, Cobenfy, which it
0 Comments
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Wall Street surged Wednesday thanks to the second encouraging inflation report this week and a batch of strong bank earnings. The consumer price index, excluding
0 Comments
In this article TDOC Follow your favorite stocksCREATE FREE ACCOUNT A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon from San Francisco! This week, Ashley and I are attending the annual JPMorgan Health Care
0 Comments